"Novartis delivered another strong quarter, with double-digit sales and core operating income growth. We continue to drive strong performance on our ongoing launches for Kisqali, Pluvicto, and ...

Ad hoc announcement pursuant to Art. 53 LR Q2 net sales grew +11% (cc1, +12% USD) with core operating income1 up +21% (cc, +20% USD) Sales growth driven by continued strong performance from ...

Novartis and eyecare spinout Alcon have agreed to settle bribery charges brought by the US federal authorities, focused on activities in Greece and other countries, for $347 million. Novartis ...

Ad hoc announcement pursuant to Art. 53 LR Q2 net sales grew +11% (cc1, +12% USD) with core operating income1 up +21% (cc, +20% USD) Sales growth driven by continued strong performance from Kisqali ...

Novartis is a “pure-play” innovative medicines company. We have a clear focus on four core therapeutic areas (cardiovascular-renal-metabolic, immunology, neuroscience and oncology), with multiple ...

Story by Jeremy Schultz • 1h 1 / 11 ©Thomson Reuters ...

Today education is associated with information technologies substantial in regards to content delivery, communication and collaboration. Cloud computing is being adopted by educational institutions at ...

Hector’s Deli is one of Melbourne’s favourite sandwich shops. The Richmond flagship and second store in South Melbourne regularly draw crowds. This third outpost in Fitzroy continues that legacy. Take ...

Allogeneic hematopoietic cell transplantation is feasible in older patients with myelodysplastic syndrome.